ArticleEuropean journal of heart failure2013

Repeated intermittent administration of a ubiquitous proteasome inhibitor leads to restrictive cardiomyopathy.

Xuejun WangPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.